Literature DB >> 8642334

Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro.

Z Cai1, J Sprent.   

Abstract

The influence of costimulation on the primary response of CD8+ T cells to class I alloantigens was studied with the aid of a T cell receptor transgenic model and defined peptides as antigen. With small doses of antigen, the proliferative response of CD8+ cells was high early in culture but was of brief duration and declined to low levels by day 4; this abbreviated response was associated with limited production of interleukin 2 (IL-2) and was strongly dependent upon costimulation via CD8-major histocompatibility complex class I and CD28-B7 interactions. The response to large doses of antigen was quite different in two respects. First, large doses of antigen inhibited the early (day 3) proliferative response but caused a marked elevation of the response late in culture (day 5); these altered kinetics were associated with increased production of IL-2. Second, the initial proliferative response to large doses of antigen did not require costimulation: indeed, blocking costimulation with CTLA4lg or anti-CD8 monoclonal antibody enhanced the early proliferative response. However, blocking costimulation impaired IL-2 production and prevented the late proliferative response. These findings indicate that the requirement for costimulation of T cells can be partly overcome by increasing the dose of antigen to a high level. However, costimulation plays a key role in prolonging the response, presumably by triggering strong and sustained production of IL-2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642334      PMCID: PMC2192558          DOI: 10.1084/jem.183.5.2247

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  Major histocompatibility complex (MHC)-encoded HAM2 is necessary for antigenic peptide loading onto class I MHC molecules.

Authors:  Y Yang; K Früh; J Chambers; J B Waters; L Wu; T Spies; P A Peterson
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

Review 2.  Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

Authors:  R H Schwartz
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

Review 3.  The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation.

Authors:  C A Janeway
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

4.  T cell reactivity to MHC molecules: immunity versus tolerance.

Authors:  J Sprent; E K Gao; S R Webb
Journal:  Science       Date:  1990-06-15       Impact factor: 47.728

5.  Evidence for CD8-independent T cell maturation in transgenic mice.

Authors:  J H Russell; P Meleedy-Rey; D E McCulley; W C Sha; C A Nelson; D Y Loh
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

6.  Antigen-presenting cells for Lyt-2+ cells. II. Primary mixed-lymphocyte reactions stimulated by Ia+ dendritic cells and Ia- peritoneal exudate cells.

Authors:  J Sprent; M Schaefer
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

7.  Positive selection of transgenic receptor-bearing thymocytes by Kb antigen is altered by Kb mutations that involve peptide binding.

Authors:  W C Sha; C A Nelson; R D Newberry; J K Pullen; L R Pease; J H Russell; D Y Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 8.  The role of the CD28 receptor during T cell responses to antigen.

Authors:  P S Linsley; J A Ledbetter
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

9.  A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein.

Authors:  K Udaka; T J Tsomides; H N Eisen
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

10.  Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.

Authors:  P S Linsley; J L Greene; P Tan; J Bradshaw; J A Ledbetter; C Anasetti; N K Damle
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  14 in total

1.  Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.

Authors:  Samantha E Kerry; Jennifer Buslepp; Lorraine A Cramer; Robert Maile; Lucinda L Hensley; Alma I Nielsen; Paula Kavathas; Barbara J Vilen; Edward J Collins; Jeffrey A Frelinger
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

2.  Mechanisms by which chronic ethanol feeding limits the ability of dendritic cells to stimulate T-cell proliferation.

Authors:  Ji Fan; Michelle R Edsen-Moore; Lucas E Turner; Robert T Cook; Kevin L Legge; Thomas J Waldschmidt; Annette J Schlueter
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

3.  Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals.

Authors:  S K Kim; D S Reed; S Olson; M J Schnell; J K Rose; P A Morton; L Lefrançois
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

4.  Transfected Drosophila cells as a probe for defining the minimal requirements for stimulating unprimed CD8+ T cells.

Authors:  Z Cai; A Brunmark; M R Jackson; D Loh; P A Peterson; J Sprent
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Accelerated HER-2 degradation enhances ovarian tumor recognition by CTL. Implications for tumor immunogenicity.

Authors:  A Castilleja; N E Ward; C A O'Brian; B Swearingen; E Swan; M A Gillogly; J L Murray; A P Kudelka; D M Gershenson; C G Ioannides
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

6.  Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.

Authors:  H N Lode; R Xiang; U Pertl; E Förster; S P Schoenberger; S D Gillies; R A Reisfeld
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  Memory CD8 T cells require CD8 coreceptor engagement for calcium mobilization and proliferation, but not cytokine production.

Authors:  Samantha E Kerry; Robert Maile; Edward J Collins; Jeffrey A Frelinger
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

8.  Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

Authors:  Shahram Salek-Ardakani; Ramon Arens; Rachel Flynn; Alessandro Sette; Stephen P Schoenberger; Michael Croft
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.

Authors:  Javier O Valenzuela; Cristina Iclozan; Mohammad S Hossain; Martin Prlic; Emily Hopewell; Crystina C Bronk; Junmei Wang; Esteban Celis; Robert W Engelman; Bruce R Blazar; Michael J Bevan; Edmund K Waller; Xue-Zhong Yu; Amer A Beg
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

10.  LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.

Authors:  Armin Bender; Julia Karbach; Antje Neumann; Dirk Jäger; Salah E Al-Batran; Akin Atmaca; Eckhart Weidmann; Melina Biskamp; Sacha Gnjatic; Linda Pan; Eric Hoffman; Lloyd J Old; Alexander Knuth; Elke Jäger
Journal:  Cancer Immun       Date:  2007-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.